Page last updated: 2024-10-18

imidazole and Idiopathic Parkinson Disease

imidazole has been researched along with Idiopathic Parkinson Disease in 3 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García, AM1
Salado, IG1
Perez, DI1
Brea, J1
Morales-García, JA1
González-García, A1
Cadavid, MI1
Loza, MI1
Luque, FJ1
Perez-Castillo, A1
Martinez, A1
Gil, C1
Ijaz, N1
Fitzgerald, D1
Chung, JY1
Lee, JW1
Ryu, CH1
Min, HK1
Yoon, YJ1
Lim, MJ1
Park, CH1

Other Studies

3 other studies available for imidazole and Idiopathic Parkinson Disease

ArticleYear
Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson's disease.
    Future medicinal chemistry, 2017, Volume: 9, Issue:8

    Topics: Cell Line, Tumor; Cell Survival; Humans; Imidazoles; Models, Molecular; Molecular Structure; Parkins

2017
Seborrhoeic dermatitis.
    British journal of hospital medicine (London, England : 2005), 2017, Jun-02, Volume: 78, Issue:6

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antifungal Agents; Brain Injuries, Traumatic; Ca

2017
1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
    Journal of neuroscience research, 2015, Volume: 93, Issue:8

    Topics: Animals; Cell Count; Disease Models, Animal; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbre

2015